# VRK1

## Overview
VRK1 (vaccinia-related kinase 1) is a gene that encodes the VRK serine/threonine kinase 1, a member of the serine/threonine kinase family. This protein plays a pivotal role in regulating various cellular processes, including cell cycle progression, chromatin condensation, and DNA damage response. VRK1 is predominantly localized in the nucleus, where it phosphorylates key substrates such as histone H3 and the tumor suppressor protein p53, thereby influencing chromatin structure and cell cycle checkpoints (Moura2018VRK1; Valbuena2011Roles). The kinase is also involved in the assembly and maintenance of nuclear structures like Cajal bodies, which are essential for RNA processing and ribonucleoprotein assembly (Cantarero2015VRK1). Mutations in the VRK1 gene have been linked to several neurological disorders, highlighting its significance in maintaining genomic stability and proper neuronal function (CamposDíaz2024Pathogenic).

## Structure
The VRK1 protein is a serine/threonine kinase with a primary structure consisting of 396 amino acids. It features a kinase domain at the N-terminal and a nuclear localization signal (NLS) at the C-terminal, which facilitates its localization within the nucleus (Ngow2024Structural). The secondary structure of VRK1 includes a bilobate kinase fold with eight α-helices and nine β-sheets, as revealed by NMR studies (Shin2011NMR). 

The tertiary structure of VRK1 is characterized by a typical kinase fold, with a C-terminal tail that is crucial for structural stability and catalytic activity. This tail interacts with the catalytic core, forming hydrophobic interactions with several important motifs such as the G-loop, αC, and the catalytic and activation loops (Shin2011NMR). The VRK1 structure also features a unique DYG motif in the activation loop, replacing the phenylalanine of the DFG motif in subdomain VII, and an additional αC4 helix forming hydrophobic contacts with other residues (Ngow2024Structural).

VRK1 undergoes post-translational modifications, including phosphorylation, which is essential for its function in cell cycle regulation and interaction with substrates like histone H3 and p53 (Shin2011NMR; Ngow2018Crystal). The protein's quaternary structure has not been explicitly detailed in the provided context.

## Function
VRK1 (VRK serine/threonine kinase 1) is a serine/threonine kinase that plays a critical role in various cellular processes essential for cell division and genomic stability in healthy human cells. It is primarily located in the nucleus but is also found in the Golgi apparatus and some cytosolic vesicles (Valbuena2011Roles).

VRK1 is involved in the regulation of the cell cycle, particularly in mitosis. It phosphorylates histone H3 at threonine 3 (Thr3), which is crucial for chromatin condensation and centromere formation, facilitating proper chromosome segregation (Moura2018VRK1). VRK1 also interacts with Aurora B kinase (AURKB), forming a complex that regulates their kinase activities and affects histone H3 phosphorylation, necessary for chromatin organization during mitosis (Moura2018VRK1).

In addition to its role in mitosis, VRK1 phosphorylates the tumor suppressor protein p53 at Thr18, influencing cell cycle checkpoints and DNA damage responses (Valbuena2011Roles). It also plays a role in the assembly and stability of Cajal bodies by phosphorylating coilin, protecting it from proteasomal degradation, and ensuring proper nuclear structure and function (Cantarero2015VRK1).

## Clinical Significance
Mutations in the VRK1 gene are associated with a range of neurological disorders, primarily affecting motor neurons. These include spinal muscular atrophy (SMA), pontocerebellar hypoplasia (PCH), microcephaly, amyotrophic lateral sclerosis (ALS), and distal hereditary motor neuropathies (dHMN) (MartínDoncel2019VRK1; CamposDíaz2024Pathogenic). The pathogenic variants of VRK1 often result in reduced protein stability or altered kinase activity, impacting substrates involved in DNA damage response and chromatin remodeling (MartínDoncel2019VRK1).

Specific mutations, such as R358X, H119R, and R321C, have been linked to distinct phenotypes, including SMA, PCH, and ALS (MartínDoncel2019VRK1). Novel mutations like p.Arg219Ile and p.Trp254Leu have been identified in patients with distal hereditary motor neuropathy, leading to decreased VRK1 levels and mislocalization, which affects motor neuron function (ElBazzal2019Loss).

VRK1 mutations can also lead to the loss of Cajal bodies in motor neurons, contributing to impaired neurite outgrowth and branching (ElBazzal2019Loss). The gene's dysfunction is implicated in a variety of motor neuron diseases, with clinical presentations ranging from early-onset to adult-onset forms, often characterized by progressive muscle weakness and atrophy (CamposDíaz2024Pathogenic; Greenbaum2020Identification).

## Interactions
VRK1 (VRK serine/threonine kinase 1) is involved in numerous interactions with proteins and nucleic acids, playing a critical role in cellular processes. VRK1 interacts with core histones, including H2B, H3, and H4, and phosphorylates histone H3 at Thr3 and Ser10, which is crucial for chromatin condensation during mitosis (Kang2007Mitotic). It also interacts with gamma heterochromatin protein 1 (HP1γ) and BAF, influencing chromatin structure and function (Kang2007Mitotic).

VRK1 forms a complex with AURKB, a kinase involved in mitosis, and this interaction cross-inhibits their kinase activities, affecting the phosphorylation of histone H3 and p53 (Moura2018VRK1). VRK1 also interacts with Ran-GTP, which regulates its kinase activity, and with Ran-GDP, which inhibits it (Valbuena2011Roles).

In the context of DNA damage response, VRK1 interacts with NBS1 and 53BP1, phosphorylating them to facilitate DNA repair processes (CampilloMarcos2021The; CampilloMarcos2018Implication). VRK1 also forms a stable complex with p53, influencing its stability and function in response to DNA damage (CampilloMarcos2021The; LópezSánchez2014VRK1).


## References


1. (Ngow2024Structural) Structural characterization of vaccinia-related kinase 1 (VRK1), a histone mitotic kinase. This article has 0 citations.

[2. (Moura2018VRK1) David S. Moura, Ignacio Campillo-Marcos, Marta Vázquez-Cedeira, and Pedro A. Lazo. Vrk1 and aurkb form a complex that cross inhibit their kinase activity and the phosphorylation of histone h3 in the progression of mitosis. Cellular and Molecular Life Sciences, 75(14):2591–2611, January 2018. URL: http://dx.doi.org/10.1007/s00018-018-2746-7, doi:10.1007/s00018-018-2746-7. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-018-2746-7)

[3. (MartínDoncel2019VRK1) Elena Martín-Doncel, Ana M. Rojas, Lara Cantarero, and Pedro A. Lazo. Vrk1 functional insufficiency due to alterations in protein stability or kinase activity of human vrk1 pathogenic variants implicated in neuromotor syndromes. Scientific Reports, September 2019. URL: http://dx.doi.org/10.1038/s41598-019-49821-7, doi:10.1038/s41598-019-49821-7. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-49821-7)

[4. (CamposDíaz2024Pathogenic) Aurora Campos-Díaz, Patricia Morejón-García, Eva Monte-Serrano, David Ros-Pardo, Iñigo Marcos-Alcalde, Paulino Gómez-Puertas, and Pedro A. Lazo. Pathogenic effects of leu200pro and arg387his vrk1 protein variants on phosphorylation targets and h4k16 acetylation in distal hereditary motor neuropathy. Journal of Molecular Medicine, 102(6):801–817, March 2024. URL: http://dx.doi.org/10.1007/s00109-024-02442-8, doi:10.1007/s00109-024-02442-8. This article has 0 citations.](https://doi.org/10.1007/s00109-024-02442-8)

[5. (Greenbaum2020Identification) Lior Greenbaum, Ortal Barel, Vera Nikitin, Adi Hersalis‐Eldar, Nitzan Kol, Haike Reznik‐Wolf, Dan Dominissini, Elon Pras, and Amir Dori. Identification of a homozygous vrk1 mutation in two patients with adult‐onset distal hereditary motor neuropathy. Muscle &amp; Nerve, 61(3):395–400, January 2020. URL: http://dx.doi.org/10.1002/mus.26779, doi:10.1002/mus.26779. This article has 8 citations.](https://doi.org/10.1002/mus.26779)

[6. (LópezSánchez2014VRK1) Inmaculada López-Sánchez, Alberto Valbuena, Marta Vázquez-Cedeira, Jyoti Khadake, Marta Sanz-García, Alejandro Carrillo-Jiménez, and Pedro A. Lazo. Vrk1 interacts with p53 forming a basal complex that is activated by uv‐induced dna damage. FEBS Letters, 588(5):692–700, January 2014. URL: http://dx.doi.org/10.1016/j.febslet.2014.01.040, doi:10.1016/j.febslet.2014.01.040. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.febslet.2014.01.040)

[7. (CampilloMarcos2021The) Ignacio Campillo-Marcos, Raúl García-González, Elena Navarro-Carrasco, and Pedro A. Lazo. The human vrk1 chromatin kinase in cancer biology. Cancer Letters, 503:117–128, April 2021. URL: http://dx.doi.org/10.1016/j.canlet.2020.12.032, doi:10.1016/j.canlet.2020.12.032. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2020.12.032)

[8. (CampilloMarcos2018Implication) Ignacio Campillo-Marcos and Pedro A. Lazo. Implication of the vrk1 chromatin kinase in the signaling responses to dna damage: a therapeutic target? Cellular and Molecular Life Sciences, 75(13):2375–2388, April 2018. URL: http://dx.doi.org/10.1007/s00018-018-2811-2, doi:10.1007/s00018-018-2811-2. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-018-2811-2)

[9. (Shin2011NMR) Joon Shin, Goutam Chakraborty, Nagakumar Bharatham, CongBao Kang, Naoya Tochio, Seizo Koshiba, Takanori Kigawa, Wanil Kim, Kyong-Tai Kim, and Ho Sup Yoon. Nmr solution structure of human vaccinia-related kinase 1 (vrk1) reveals the c-terminal tail essential for its structural stability and autocatalytic activity. Journal of Biological Chemistry, 286(25):22131–22138, June 2011. URL: http://dx.doi.org/10.1074/jbc.M110.200162, doi:10.1074/jbc.m110.200162. This article has 45 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M110.200162)

[10. (ElBazzal2019Loss) Lara El-Bazzal, Khalil Rihan, Nathalie Bernard-Marissal, Christel Castro, Eliane Chouery-Khoury, Jean-Pierre Desvignes, Alexandre Atkinson, Karine Bertaux, Salam Koussa, Nicolas Lévy, Marc Bartoli, André Mégarbané, Rosette Jabbour, and Valérie Delague. Loss of cajal bodies in motor neurons from patients with novel mutations in vrk1. Human Molecular Genetics, 28(14):2378–2394, April 2019. URL: http://dx.doi.org/10.1093/hmg/ddz060, doi:10.1093/hmg/ddz060. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddz060)

[11. (Cantarero2015VRK1) Lara Cantarero, Marta Sanz-García, Hadar Vinograd-Byk, Paul Renbaum, Ephrat Levy-Lahad, and Pedro A. Lazo. Vrk1 regulates cajal body dynamics and protects coilin from proteasomal degradation in cell cycle. Scientific Reports, June 2015. URL: http://dx.doi.org/10.1038/srep10543, doi:10.1038/srep10543. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep10543)

[12. (Valbuena2011Roles) Alberto Valbuena, Marta Sanz-García, Inmaculada López-Sánchez, Francisco M. Vega, and Pedro A. Lazo. Roles of vrk1 as a new player in the control of biological processes required for cell division. Cellular Signalling, 23(8):1267–1272, August 2011. URL: http://dx.doi.org/10.1016/j.cellsig.2011.04.002, doi:10.1016/j.cellsig.2011.04.002. This article has 76 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2011.04.002)

[13. (Ngow2018Crystal) Yeen Shian Ngow, Sreekanth Rajan, Hong Ye, and Ho Sup Yoon. Crystal structure of human vaccinia‐related kinase 1 in complex with amp‐pnp, a non‐hydrolyzable atp analog. Protein Science, 28(3):524–532, December 2018. URL: http://dx.doi.org/10.1002/pro.3552, doi:10.1002/pro.3552. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/pro.3552)

[14. (Kang2007Mitotic) Tae-Hong Kang, Do-Young Park, Yoon Ha Choi, Kyung-Jin Kim, Ho Sup Yoon, and Kyong-Tai Kim. Mitotic histone h3 phosphorylation by vaccinia-related kinase 1 in mammalian cells. Molecular and Cellular Biology, 27(24):8533–8546, December 2007. URL: http://dx.doi.org/10.1128/mcb.00018-07, doi:10.1128/mcb.00018-07. This article has 124 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.00018-07)